1. Home
  2. INKT vs GROW Comparison

INKT vs GROW Comparison

Compare INKT & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • GROW
  • Stock Information
  • Founded
  • INKT 2017
  • GROW 1968
  • Country
  • INKT United States
  • GROW United States
  • Employees
  • INKT N/A
  • GROW N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • GROW Investment Managers
  • Sector
  • INKT Health Care
  • GROW Finance
  • Exchange
  • INKT Nasdaq
  • GROW Nasdaq
  • Market Cap
  • INKT 43.0M
  • GROW 32.9M
  • IPO Year
  • INKT 2021
  • GROW N/A
  • Fundamental
  • Price
  • INKT $11.10
  • GROW $2.45
  • Analyst Decision
  • INKT Strong Buy
  • GROW
  • Analyst Count
  • INKT 2
  • GROW 0
  • Target Price
  • INKT $6.50
  • GROW N/A
  • AVG Volume (30 Days)
  • INKT 70.4K
  • GROW 28.7K
  • Earning Date
  • INKT 03-20-2025
  • GROW 02-14-2025
  • Dividend Yield
  • INKT N/A
  • GROW 3.67%
  • EPS Growth
  • INKT N/A
  • GROW N/A
  • EPS
  • INKT N/A
  • GROW 0.12
  • Revenue
  • INKT N/A
  • GROW $10,008,000.00
  • Revenue This Year
  • INKT N/A
  • GROW N/A
  • Revenue Next Year
  • INKT N/A
  • GROW N/A
  • P/E Ratio
  • INKT N/A
  • GROW $20.47
  • Revenue Growth
  • INKT N/A
  • GROW N/A
  • 52 Week Low
  • INKT $4.56
  • GROW $2.38
  • 52 Week High
  • INKT $19.00
  • GROW $2.95
  • Technical
  • Relative Strength Index (RSI)
  • INKT 59.45
  • GROW 51.55
  • Support Level
  • INKT $7.32
  • GROW $2.43
  • Resistance Level
  • INKT $13.79
  • GROW $2.50
  • Average True Range (ATR)
  • INKT 2.06
  • GROW 0.04
  • MACD
  • INKT 0.26
  • GROW 0.00
  • Stochastic Oscillator
  • INKT 70.86
  • GROW 50.00

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: